SG Americas Securities, LLC - EIDOS THERAPEUTICS INC ownership

EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 91 filers reported holding EIDOS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.5%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of EIDOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$997,000
+136.3%
20,911
+142.8%
0.01%
+100.0%
Q1 2020$422,000
-58.0%
8,612
-50.8%
0.00%
-55.6%
Q4 2019$1,005,000
-30.8%
17,509
-56.6%
0.01%
-25.0%
Q3 2019$1,452,000
+1061.6%
40,357
+903.4%
0.01%
+1100.0%
Q2 2019$125,0004,0220.00%
Other shareholders
EIDOS THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,123,630$56,777,00018.14%
Board of Trustees of The Leland Stanford Junior University 265,670$13,425,0005.17%
Opaleye Management Inc. 315,550$15,945,0003.12%
RA Capital Management 2,163,271$109,310,0002.00%
Cormorant Asset Management, LP 993,185$50,186,0001.93%
Parkman Healthcare Partners LLC 41,091$2,076,0000.55%
Perceptive Advisors 686,922$34,710,0000.51%
Redmile Group, LLC 466,205$23,557,0000.43%
Eventide Asset Management 317,417$16,039,0000.31%
Ikarian Capital, LLC 63,011$3,184,0000.23%
View complete list of EIDOS THERAPEUTICS INC shareholders